机构

• 上海药物研究所 [111]

采集方式

• OAI收割 [111]

内容类型

• 期刊论文 [108]
• 学位论文 [2]
• 会议论文 [1]

发表日期

• 2022 [4]
• 2020 [3]
• 2019 [7]
• 2018 [9]
• 2017 [4]
• 2016 [7]
• 更多

学科主题

• Oncology [2]
• Biotechnol... [1]
• Cell Biolo... [1]
• Chemistry [1]
• Microbiolo... [1]
• Mycology [1]
• 更多

筛选

浏览/检索结果: 共111条，第1-10条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Suppression of Pathological Ocular Neovascularization by a Small Molecular Multi-Targeting Kinase Inhibitor, DCZ19903 期刊论文  OAI收割 TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2022, 卷号: 11, 期号: 12, 页码: 15 作者:  Ding, Jingjuan;  Li, Bo;  Zhang, Huiying;  Xu, Zhijian;  Zhang, Qiuyang   |  收藏  |  浏览/下载：5/0  |  提交时间：2023/10/17 ocular neovascularization  DCZ19903  multitarget kinase inhibitor  network pharmacology  MAPK signaling pathway   Multiple-dose up-titration study to evaluate the pharmacokinetics, safety and antitumor activity of apatinib in advanced gastric adenocarcinoma 期刊论文  OAI收割 FRONTIERS IN ONCOLOGY, 2022, 卷号: 12, 页码: 10 作者:  Wang, Yonggang;  Wang, Chang;  Zhang, Yanqiao;  Hao, Jiqing;  Yang, Nong   |  收藏  |  浏览/下载：26/0  |  提交时间：2022/12/13 apatinib  angiogenesis  gastric adenocarcinoma  pharmacokinetics  VEGFR  VEGFR-2   Dual-responsive nanoparticles loading bevacizumab and gefitinib for molecular targeted therapy against non-small cell lung cancer 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022, 页码: 11 作者:  Zhao, Zi-tong;  Wang, Jue;  Fang, Lei;  Qian, Xin-di;  Cai, Ying   |  收藏  |  浏览/下载：37/0  |  提交时间：2022/08/16 nanoparticles  molecular targeted therapy  non-small cell lung cancer  dual-responsive  controlled release   Design and semisynthesis of oleanolic acid derivatives as VEGF in- hibitors: Inhibition of VEGF-induced proliferation, angiogenesis, and VEGFR2 activation in HUVECs 期刊论文  OAI收割 CHINESE JOURNAL OF NATURAL MEDICINES, 2022, 卷号: 20, 期号: 3, 页码: 229-240 作者:  Meng Ning;  Xie Hong-Xu;  Hou Jia-Rong;  Chen Yon-Bin;  Wu Meng-Jun   |  收藏  |  浏览/下载：21/0  |  提交时间：2022/06/15 Oleanolic acid  Structural modification  VEGF inhibitor  VEGFR2  Angiogenesis   A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2021, 卷号: 11, 期号: 1, 页码: 283-299 作者:  Li, Jinyang;  Lu, Jiasheng;  Guo, Haiyan;  Zhou, Jianfen;  Wang, Songli   |  收藏  |  浏览/下载：29/0  |  提交时间：2021/05/24 Liposome  mn  c(RGDyK)  Immune opsonization  Immunogenicity  Anti-glioma efficacy   Emerging roles of class I PI3K inhibitors in modulating tumor microenvironment and immunity 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 8 作者:  Sun, Pu;  Meng, Ling-hua   |  收藏  |  浏览/下载：21/0  |  提交时间：2020/12/21 phosphoinositide 3-kinase (PI3K)  PI3K inhibitors  tumor microenvironment  immune cells  immunotherapy   Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate 期刊论文  OAI收割 FASEB JOURNAL, 2020, 页码: 18 作者:  Hait, Nitai C.;  Maiti, Aparna;  Xu, Pan;  Qi, Qianya;  Kawaguchi, Tsutomu   |  收藏  |  浏览/下载：14/0  |  提交时间：2020/07/01 hypoxia-inducible factors  sphingosine-1-phosphate  sphingosine kinase 2  triple-negative breast cancer   Inhibition of Tumor Lymphangiogenesis is an Important Part that EGFR-TKIs Play in the Treatment of NSCLC 期刊论文  OAI收割 JOURNAL OF CANCER, 2020, 卷号: 11, 期号: 1, 页码: 241-250 作者:  Zhang, Yan;  Yang, Xinying;  Liu, Hongchun;  Cai, Minghui;  Yang Shentu   |  收藏  |  浏览/下载：64/0  |  提交时间：2020/07/01 EGFR-TKIs  NSCLC  lymphangiogenesis  JAK/STAT3  LYVE-1   DZ2002 ameliorates fibrosis, inflammation, and vasculopathy in experimental systemic sclerosis models 期刊论文  OAI收割 ARTHRITIS RESEARCH & THERAPY, 2019, 卷号: 21, 期号: 1, 页码: 15 作者:  Zhang, Zongwang;  Wu, Yanwei;  Wu, Bing;  Qi, Qing;  Li, Heng   |  收藏  |  浏览/下载：24/0  |  提交时间：2020/07/01 Systemic sclerosis  SAHH inhibitor  Fibrosis  Inflammation  Vasculopathy  TGF-beta   Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models 期刊论文  OAI收割 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 卷号: 38, 期号: 1, 页码: 16 作者:  Peng, Xia;  Hou, Pengcong;  Chen, Yi;  Dai, Yang;  Ji, Yinchun   |  收藏  |  浏览/下载：23/0  |  提交时间：2020/07/01 Kinase inhibitor  FGFR  CSF-1R  Tumor microenvironment